← Back to Search

Culturally-appropriate social marketing campaign for Coronavirus

N/A
Waitlist Available
Led By Jennifer C Erves, PhD
Research Sponsored by Meharry Medical College
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
African American
Unvaccinated for COVID-19
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights

Study Summary

This trial is testing a social marketing intervention to increase confidence in the COVID-19 vaccine among African Americans in Nashville/Davidson County, Tennessee. The study's novelty lies in being the first to assess feasibility and preliminary efficacy of a multi-layered, culturally-appropriate social marketing intervention to promote COVID-19 vaccination among African Americans in TN.

Eligible Conditions
  • Coronavirus
  • Vaccine Refusal
  • Communication

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Recruitment rates
Retention rates
data collection processes
Secondary outcome measures
Attitudes toward COVID-19 vaccine
COVID-19 vaccine rates

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: Culturally-appropriate social marketing campaignExperimental Treatment1 Intervention
Participants will receive a multi-layered, social marketing campaign which is deemed culturally appropriate. This will occur over a 6 month -time period. Rates will be observed at 0, 6, and 12 months.
Group II: Control Arm 1Active Control1 Intervention
Participants will receive no intervention, only to serve as a control site. Rates will be observed at 0, 6, and 12 months.
Group III: Control Arm 2Active Control1 Intervention
Participants will receive no intervention, only to serve as a control site. Rates will be observed at 0, 6, and 12 months.

Find a Location

Who is running the clinical trial?

Meharry Medical CollegeLead Sponsor
18 Previous Clinical Trials
5,684 Total Patients Enrolled
St. Jude Children's Research HospitalOTHER
426 Previous Clinical Trials
5,306,305 Total Patients Enrolled
Jennifer C Erves, PhDPrincipal InvestigatorMeharry Medical College

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~78 spots leftby Mar 2025